We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The Sheffield Institute for Translational Neuroscience (SITraN) announced that its research into a drug candidate, discovered by British artificial intelligence firm BenevolentAI, has delivered positive results.